Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6071319
[patent_doc_number] => 20110046170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'NOVEL PYRIMIDINE-PYRIDINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/920572
[patent_app_country] => US
[patent_app_date] => 2009-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27904
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20110046170.pdf
[firstpage_image] =>[orig_patent_app_number] => 12920572
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/920572 | NOVEL PYRIMIDINE-PYRIDINE DERIVATIVES | Mar 2, 2009 | Abandoned |
Array
(
[id] => 8469921
[patent_doc_number] => 08299099
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-30
[patent_title] => 'Heteroaryl derivatives as CFTR modulators'
[patent_app_type] => utility
[patent_app_number] => 12/392298
[patent_app_country] => US
[patent_app_date] => 2009-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23075
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12392298
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/392298 | Heteroaryl derivatives as CFTR modulators | Feb 24, 2009 | Issued |
Array
(
[id] => 5436290
[patent_doc_number] => 20090170877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => '5,6-Trimethylenepyrimidin-4-one compounds'
[patent_app_type] => utility
[patent_app_number] => 12/372837
[patent_app_country] => US
[patent_app_date] => 2009-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16148
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20090170877.pdf
[firstpage_image] =>[orig_patent_app_number] => 12372837
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/372837 | 5,6-Trimethylenepyrimidin-4-one compounds | Feb 17, 2009 | Abandoned |
Array
(
[id] => 5515452
[patent_doc_number] => 20090215759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'MODULATORS FOR AMYLOID BETA'
[patent_app_type] => utility
[patent_app_number] => 12/371729
[patent_app_country] => US
[patent_app_date] => 2009-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63590
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215759.pdf
[firstpage_image] =>[orig_patent_app_number] => 12371729
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/371729 | MODULATORS FOR AMYLOID BETA | Feb 15, 2009 | Abandoned |
Array
(
[id] => 5929734
[patent_doc_number] => 20110039693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'Pyrimidylmethyl Sulfonamide Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/867548
[patent_app_country] => US
[patent_app_date] => 2009-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45186
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039693.pdf
[firstpage_image] =>[orig_patent_app_number] => 12867548
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/867548 | Pyrimidylmethyl Sulfonamide Compounds | Feb 9, 2009 | Abandoned |
Array
(
[id] => 6136396
[patent_doc_number] => 20110009369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'ANTI-INFLUENZA COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/866118
[patent_app_country] => US
[patent_app_date] => 2009-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4089
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20110009369.pdf
[firstpage_image] =>[orig_patent_app_number] => 12866118
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/866118 | Anti-influenza compounds | Feb 3, 2009 | Issued |
Array
(
[id] => 6631345
[patent_doc_number] => 20100311776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'Novel sEH Inhibitors and their Use'
[patent_app_type] => utility
[patent_app_number] => 12/864721
[patent_app_country] => US
[patent_app_date] => 2009-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10656
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311776.pdf
[firstpage_image] =>[orig_patent_app_number] => 12864721
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/864721 | Novel sEH Inhibitors and their Use | Jan 29, 2009 | Abandoned |
Array
(
[id] => 5279331
[patent_doc_number] => 20090131463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'NOVEL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/359541
[patent_app_country] => US
[patent_app_date] => 2009-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23931
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20090131463.pdf
[firstpage_image] =>[orig_patent_app_number] => 12359541
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/359541 | NOVEL COMPOUNDS | Jan 25, 2009 | Abandoned |
Array
(
[id] => 5527980
[patent_doc_number] => 20090198057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'Certain Chemical Entities, Compositions, and Methods'
[patent_app_type] => utility
[patent_app_number] => 12/359177
[patent_app_country] => US
[patent_app_date] => 2009-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14750
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20090198057.pdf
[firstpage_image] =>[orig_patent_app_number] => 12359177
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/359177 | Certain Chemical Entities, Compositions, and Methods | Jan 22, 2009 | Abandoned |
Array
(
[id] => 6149952
[patent_doc_number] => 20110021547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'Substantially Pure and a Stable Crystalline Form of Bosentan'
[patent_app_type] => utility
[patent_app_number] => 12/864571
[patent_app_country] => US
[patent_app_date] => 2009-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14230
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20110021547.pdf
[firstpage_image] =>[orig_patent_app_number] => 12864571
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/864571 | Substantially Pure and a Stable Crystalline Form of Bosentan | Jan 21, 2009 | Abandoned |
Array
(
[id] => 10142172
[patent_doc_number] => 09174970
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-03
[patent_title] => '5-fluoro pyrimidine derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/357710
[patent_app_country] => US
[patent_app_date] => 2009-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28433
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12357710
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/357710 | 5-fluoro pyrimidine derivatives | Jan 21, 2009 | Issued |
Array
(
[id] => 5563647
[patent_doc_number] => 20090136499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'RAF Inhibitors and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/356097
[patent_app_country] => US
[patent_app_date] => 2009-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 46625
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20090136499.pdf
[firstpage_image] =>[orig_patent_app_number] => 12356097
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/356097 | RAF Inhibitors and Uses Thereof | Jan 19, 2009 | Abandoned |
Array
(
[id] => 7491722
[patent_doc_number] => 08030483
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-04
[patent_title] => 'Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses'
[patent_app_type] => utility
[patent_app_number] => 12/355155
[patent_app_country] => US
[patent_app_date] => 2009-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 20668
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/030/08030483.pdf
[firstpage_image] =>[orig_patent_app_number] => 12355155
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/355155 | Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses | Jan 15, 2009 | Issued |
Array
(
[id] => 5564755
[patent_doc_number] => 20090137608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor'
[patent_app_type] => utility
[patent_app_number] => 12/321208
[patent_app_country] => US
[patent_app_date] => 2009-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16096
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20090137608.pdf
[firstpage_image] =>[orig_patent_app_number] => 12321208
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/321208 | Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor | Jan 14, 2009 | Abandoned |
Array
(
[id] => 7593182
[patent_doc_number] => 07652019
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-26
[patent_title] => '5,6-trimethylenepyrimidin-4-one compounds'
[patent_app_type] => utility
[patent_app_number] => 12/349086
[patent_app_country] => US
[patent_app_date] => 2009-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16305
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/652/07652019.pdf
[firstpage_image] =>[orig_patent_app_number] => 12349086
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/349086 | 5,6-trimethylenepyrimidin-4-one compounds | Jan 5, 2009 | Issued |
Array
(
[id] => 7550735
[patent_doc_number] => 08063068
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-22
[patent_title] => 'Arylvinylazacycloalkane compounds and methods of preparation and use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/348605
[patent_app_country] => US
[patent_app_date] => 2009-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13812
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/063/08063068.pdf
[firstpage_image] =>[orig_patent_app_number] => 12348605
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/348605 | Arylvinylazacycloalkane compounds and methods of preparation and use thereof | Jan 4, 2009 | Issued |
Array
(
[id] => 6450713
[patent_doc_number] => 20100280244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'PROCESS FOR PREPARING N-SUBSTITUTED HYDROXYPYRIMIDINONE CARBOXAMIDES'
[patent_app_type] => utility
[patent_app_number] => 12/811254
[patent_app_country] => US
[patent_app_date] => 2008-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20350
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20100280244.pdf
[firstpage_image] =>[orig_patent_app_number] => 12811254
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/811254 | Process for preparing N-substituted hydroxypyrimidinone carboxamides | Dec 21, 2008 | Issued |
Array
(
[id] => 5331361
[patent_doc_number] => 20090111838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-30
[patent_title] => '6-ARYLAMINO-5-CYANO-4-PYRIMIDINONES AS PDE9A INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/339393
[patent_app_country] => US
[patent_app_date] => 2008-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10967
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20090111838.pdf
[firstpage_image] =>[orig_patent_app_number] => 12339393
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/339393 | 6-ARYLAMINO-5-CYANO-4-PYRIMIDINONES AS PDE9A INHIBITORS | Dec 18, 2008 | Abandoned |
Array
(
[id] => 6127507
[patent_doc_number] => 20110086759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'CHEMICAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/810455
[patent_app_country] => US
[patent_app_date] => 2008-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70403
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20110086759.pdf
[firstpage_image] =>[orig_patent_app_number] => 12810455
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/810455 | CHEMICAL COMPOUNDS | Dec 17, 2008 | Abandoned |
Array
(
[id] => 5398441
[patent_doc_number] => 20090318504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods'
[patent_app_type] => utility
[patent_app_number] => 12/314675
[patent_app_country] => US
[patent_app_date] => 2008-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 108531
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318504.pdf
[firstpage_image] =>[orig_patent_app_number] => 12314675
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/314675 | Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods | Dec 14, 2008 | Abandoned |